AXGN
Price
$13.37
Change
+$0.16 (+1.21%)
Updated
Jul 25 closing price
Capitalization
348.67M
9 days until earnings call
TRIB
Price
$0.67
Change
-$0.03 (-4.29%)
Updated
Jul 25 closing price
Capitalization
14.9M
Interact to see
Advertisement

AXGN vs TRIB

Header iconAXGN vs TRIB Comparison
Open Charts AXGN vs TRIBBanner chart's image
Axogen
Price$13.37
Change+$0.16 (+1.21%)
Volume$762K
Capitalization348.67M
Trinity Biotech
Price$0.67
Change-$0.03 (-4.29%)
Volume$169.4K
Capitalization14.9M
AXGN vs TRIB Comparison Chart in %
Loading...
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXGN vs. TRIB commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXGN is a Buy and TRIB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (AXGN: $13.37 vs. TRIB: $0.67)
Brand notoriety: AXGN and TRIB are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AXGN: 99% vs. TRIB: 15%
Market capitalization -- AXGN: $348.67M vs. TRIB: $14.9M
AXGN [@Medical Specialties] is valued at $348.67M. TRIB’s [@Medical Specialties] market capitalization is $14.9M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXGN’s FA Score shows that 0 FA rating(s) are green whileTRIB’s FA Score has 1 green FA rating(s).

  • AXGN’s FA Score: 0 green, 5 red.
  • TRIB’s FA Score: 1 green, 4 red.
According to our system of comparison, AXGN is a better buy in the long-term than TRIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXGN’s TA Score shows that 5 TA indicator(s) are bullish while TRIB’s TA Score has 5 bullish TA indicator(s).

  • AXGN’s TA Score: 5 bullish, 4 bearish.
  • TRIB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AXGN is a better buy in the short-term than TRIB.

Price Growth

AXGN (@Medical Specialties) experienced а +18.53% price change this week, while TRIB (@Medical Specialties) price change was -8.24% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was +5.16%, and the average quarterly price growth was -1.87%.

Reported Earning Dates

AXGN is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXGN($349M) has a higher market cap than TRIB($14.9M). AXGN YTD gains are higher at: -18.871 vs. TRIB (-23.824). AXGN has higher annual earnings (EBITDA): -13.33M vs. TRIB (-26.34M). AXGN has more cash in the bank: 31M vs. TRIB (6.58M). TRIB (67.3M) and AXGN (69.3M) have identical debt. AXGN has higher revenues than TRIB: AXGN (159M) vs TRIB (71.4M).
AXGNTRIBAXGN / TRIB
Capitalization349M14.9M2,342%
EBITDA-13.33M-26.34M51%
Gain YTD-18.871-23.82479%
P/E RatioN/A33.00-
Revenue159M71.4M223%
Total Cash31M6.58M471%
Total Debt69.3M67.3M103%
FUNDAMENTALS RATINGS
AXGN vs TRIB: Fundamental Ratings
AXGN
TRIB
OUTLOOK RATING
1..100
3911
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
54
Fair valued
PROFIT vs RISK RATING
1..100
80100
SMR RATING
1..100
92100
PRICE GROWTH RATING
1..100
4888
P/E GROWTH RATING
1..100
10017
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AXGN's Valuation (44) in the Medical Specialties industry is in the same range as TRIB (54). This means that AXGN’s stock grew similarly to TRIB’s over the last 12 months.

AXGN's Profit vs Risk Rating (80) in the Medical Specialties industry is in the same range as TRIB (100). This means that AXGN’s stock grew similarly to TRIB’s over the last 12 months.

AXGN's SMR Rating (92) in the Medical Specialties industry is in the same range as TRIB (100). This means that AXGN’s stock grew similarly to TRIB’s over the last 12 months.

AXGN's Price Growth Rating (48) in the Medical Specialties industry is somewhat better than the same rating for TRIB (88). This means that AXGN’s stock grew somewhat faster than TRIB’s over the last 12 months.

TRIB's P/E Growth Rating (17) in the Medical Specialties industry is significantly better than the same rating for AXGN (100). This means that TRIB’s stock grew significantly faster than AXGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXGNTRIB
RSI
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 17 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRYBF0.04N/A
+4.51%
Dynamite Blockchain Corp.
AHEXF29.50N/A
N/A
Adecco Group AG
DPSTF47.80N/A
N/A
Deutsche Post AG
MONSF71.23N/A
N/A
MONTEA SICAFI
JDVB26.30N/A
N/A
JD Bancshares, Inc.

AXGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXGN has been loosely correlated with VMD. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AXGN jumps, then VMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXGN
1D Price
Change %
AXGN100%
+1.21%
VMD - AXGN
43%
Loosely correlated
-2.70%
MXCT - AXGN
35%
Loosely correlated
-0.88%
CLPT - AXGN
33%
Poorly correlated
-0.44%
XRAY - AXGN
33%
Poorly correlated
-2.61%
GMED - AXGN
33%
Poorly correlated
+2.23%
More

TRIB and

Correlation & Price change

A.I.dvisor tells us that TRIB and CODX have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TRIB and CODX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRIB
1D Price
Change %
TRIB100%
-4.08%
CODX - TRIB
21%
Poorly correlated
-1.44%
RBOT - TRIB
21%
Poorly correlated
-14.94%
AXGN - TRIB
21%
Poorly correlated
+1.21%
RGEN - TRIB
13%
Poorly correlated
N/A
QDEL - TRIB
10%
Poorly correlated
+4.03%
More